![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/41 | |
C07D 257/04 | |||
C07C 233/47 |
(11) | Number of the document | 3229799 |
(13) | Kind of document | T |
(96) | European patent application number | 15843405.0 |
Date of filing the European patent application | 2015-12-08 | |
(97) | Date of publication of the European application | 2017-10-18 |
(45) | Date of publication and mention of the grant of the patent | 2018-10-17 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2015/064432 |
Date | 2015-12-08 |
(87) | Number | WO 2016/049663 |
Date | 2016-03-31 |
(30) | Number | Date | Country code |
201462089225 P | 2014-12-08 | US |
(72) |
CHEN, Minhua, US
ZHANG, Yanfeng, CN
YANG, Chaohui, CN
ZHANG, Xiaoyu, CN
LI, Jiaoyang, CN
WANG, Peng, US
LI, Pixu, CN
|
(73) |
Crystal Pharmatech Co., Ltd.,
B4-101, Biobay, 218 Xinghu Street Suzhou Industrial Park, Suzhou, 215123,
CN
Suzhou Pengxu Pharmatech Co., Ltd., 3rd Floor, Building 7 2358 Changan Road Wujiang, Suzhou, 215200, CN |
(54) | CRYSTALLINE FORMS OF TRISODIUM SUPRAMOLECULAR COMPLEX COMPRISING VALSARTAN AND AHU-377 AND METHODS THEREOF |
CRYSTALLINE FORMS OF TRISODIUM SUPRAMOLECULAR COMPLEX COMPRISING VALSARTAN AND AHU-377 AND METHODS THEREOF |